http://ift.tt/2nLAAGL Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 900 in its research report dated May 09, 2017.
May 31, 2017 at 08:17AM
http://ift.tt/2q895tg
from
No comments:
Post a Comment